Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2022 Sep 12;10(9):e004322corr1. doi: 10.1136/jitc-2021-004322corr1

Correction: DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

PMCID: PMC9472168  PMID: 36096537

Muik A, Adams HC, Gieseke F, et al. DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. J ImmunoTher Cancer 2022;10:e004322. doi: 10.1136/jitc-2021-004322

The author Homer C Adams III has been updated to Homer C Adams 3rd.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES